METASTATIC OROPHARYNGEAL CARCINOMA
Clinical trials for METASTATIC OROPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OROPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC OROPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill combo offers new hope for rural head and neck cancer patients
Disease control Recruiting nowThis study is testing whether taking three oral chemotherapy drugs together is safe and practical for patients with head and neck cancer that has returned or spread. The trial focuses on people living in rural Midwest areas, making it easier for them to participate from home. The…
Matched conditions: METASTATIC OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Vaccine combo aims to supercharge immune attack on HPV-Positive throat cancer
Disease control Recruiting nowThis study tests whether adding two experimental HPV vaccines (pBI-11 and TA-HPV) to the standard immunotherapy drug pembrolizumab can shrink tumors or slow cancer growth in people with advanced oropharyngeal cancer that is HPV-positive. About 54 adults whose cancer has returned …
Matched conditions: METASTATIC OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Michael K. Gibson • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC